DISCOVERY, DEVELOPMENT, DEPLOYMENTFOR GLOBAL HEALTH, with SCIENCE & BUSINESS ACUMEN
MISSION
We are a professional firm that can DISCOVER technological seeds and ideas, DEVELOP them into viable products and services, and DEPLOY to the society to improve global health partnering with established corporations who share our passion
BUSINESS
INVESTMENTS
■ D3 Bio Healthcare Fund
− Venture Capital (LPS in Japan)
− FOCUS: Early Stage biotech and digital healthcare start-ups
with tech and idea potentially contribute to global
health issues
CONSULTING
■ Management advisory
■ Investment advisory
− Growth Strategy (Corporate, Business)
− New Business Development
− Innovation
− Private Equity (buyout)
− Growth Capital
TEAM
#PARTNERS
TOMOYA NAGATA, M.S. R.Ph.
Managing Partner, CEO
FIL Capital Management (HK) Ltd. | McKinsey (Strategy & Innovation) | M.S. and B.S. in Pharma. Sci., Univ. of Tokyo | UC Berkley HaaS VCEP | Registered Pharmacist
KENJI WATATANI, Ph.D.Partner, COO
McKinsey (Pharmaceuticals & Medical Products) | PD in Kyoto Univ. (iCeMS)| Ph.D. in Mol. Biol., Univ. of Tokyo
#VENTURE PARTNERS
YASUAKI HASEBE, M.D.
Venture Partner
Activaid (Founder CEO) | Novartis (Basel, Tokyo) | McKinsey | M.D., Nagoya Univ.
And more.
APPENDIX
#GOVERMENT SUBSIDY
■ Certified VC, “Strengthening Program for Pharmaceutical Startup Ecosystem”, Japan Agency for Medical Research and Development, Government of Japan#CONTRIBUTION
■ Sub Program Director, Goal9 , Moon Shot Research and Development, Cabinet Office, Government of Japan■ Principal, Japan Business Model Association
■ Management Committee, Graduate Program of Transformative Chem-Bio Research, Nagoya University